Here, we specified two initial centroids of mass, the IDH mutant type/MGMT promoter methylated samples and IDH wild type/MGMT promoter unmethylated samples, because of the strong association between IDH mutation and MGMT promoter methylation in gliomas (19, 20). This evidence concerns the gene MGMT and central nervous system cancer.